3.3 Business and Management – Pharmacoeconomics
Pharmacoeconomics
Learning Outcomes
-
Define the term pharmacoeconomics and why it is important in healthcare
-
identify the different types of costs and outcomes involved in pharmacoeconomic analysis
-
explain the basic methods of pharmacoeconomic analysis
-
apply pharmacoeconomic methods to assist in healthcare decision making.
What is Pharmacoeconomics?
Economics= The science of scarcity and choice
- Economists analyse the way in which individuals structure and prioritise their personal consumption in their attempt to maximise welfare within constrained resources
Health economics = Economics applied to healthcare
As pharmacists, we should be aware of pharmacoeconomics because it helps to understand the cost-effectiveness of medications and healthcare interventions. This knowledge allows pharmacists to make informed decisions about drug therapies, ensuring the best outcomes for patients while considering financial constraints. Pharmacoeconomics also plays a role in optimizing healthcare resource allocation, supporting value-based care, and improving access to affordable treatments. Understanding these principles is essential for pharmacists as they collaborate with healthcare teams to provide cost-effective, high-quality care.
 
Introduction to Pharmacoeconomics (Pharmacoeconomics 1)
đź“ťDownload the lecture notes here:
Pharmacoeconomics 2
Following on from the introductory pharmacoeconomics lecture, we will be exploring the different methods of pharmacoeconomic analysis and some examples of these types of analyses.
🎧 Listen to the recorded lecturesÂ
đź“ť Download the lecture notes here:
đź“š Read/Explore
Here are a few examples of articles which include one or more forms of pharmacoeconomic analysis – no need to read the entire articles but look specifically at the methods that are being used.
Cost minimization analysisÂ
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis
Cost effectiveness analysisÂ
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Cost benefit analysisÂ
Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
Cost utility analysisÂ
Cost-utility analysis of bariatric surgery
COMMONWEALTH OF AUSTRALIAÂ Copyright Regulations 1969Â WARNING
This material has been reproduced and communicated to you by or on behalf of James Cook University in accordance with section 113P of the Copyright Act 1969 (Act).
The material in this communication may be subject to copyright under the Act. Any further reproduction or communication of this material by you may be the subject of copyright protection under the Act. Do not remove this notice.